SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001683168-24-005798
Filing Date
2024-08-16
Accepted
2024-08-15 20:18:57
Documents
60
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO 1 FOR 3-31-24 coeptis_i10qa1-033124.htm   iXBRL 10-Q/A 909810
2 CERTIFICATION coeptis_ex3101.htm EX-31.1 8495
3 CERTIFICATION coeptis_ex3102.htm EX-31.2 8559
4 CERTIFICATION coeptis_ex3201.htm EX-32.2 2577
5 CERTIFICATION coeptis_ex3202.htm EX-32.2 2182
  Complete submission text file 0001683168-24-005798.txt   5827911

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE coep-20240331.xsd EX-101.SCH 44834
7 XBRL CALCULATION FILE coep-20240331_cal.xml EX-101.CAL 49670
8 XBRL DEFINITION FILE coep-20240331_def.xml EX-101.DEF 211488
9 XBRL LABEL FILE coep-20240331_lab.xml EX-101.LAB 354006
10 XBRL PRESENTATION FILE coep-20240331_pre.xml EX-101.PRE 297501
65 EXTRACTED XBRL INSTANCE DOCUMENT coeptis_i10qa1-033124_htm.xml XML 791076
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Filer) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-39669 | Film No.: 241213919
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)